Recruiting
Who we are
Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer
An Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and Metastasis
GCC19CART for Patients With Metastatic Colorectal Cancer
A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas
Chimeric Antigen Receptor T Cells Targeting claudin18.2 in Solid Tumors.
Clinical Research of ROBO1 Specific CAR-NK Cells on Patients With Solid Tumors
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone in Participants With Resected Solid Tumors and in Combination With Pembrolizumab in Participants With Unresectable Solid Tumors
A Phase Ib/IIa Study of CR6086 in Combination With Balstilimab in pMMR-MSS Metastatic Colorectal Cancer Patients
PIPAC for the Treatment of Colorectal Peritoneal Metastases
